Text Size

Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

This study is not yet open for participant recruitment.
Verified August 2012 by Maine Medical Center
Sponsor:
Information provided by (Responsible Party):
Tania D. Strout, Maine Medical Center
ClinicalTrials.gov Identifier:
NCT01656616
First received: August 1, 2012
Last updated: August 2, 2012
Last verified: August 2012
History of Changes
  Purpose

The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.


Condition Intervention
Cyanide Poisoning
 Drug: Cyanide antidote administration

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Maine Medical Center:

Estimated Enrollment: 300
Study Start Date: August 2012
Groups/Cohorts Assigned Interventions
EMS cyanide exposure patients Drug: Cyanide antidote administration

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

EMS patients possibly exposed to cyanide via poisoning or smoke exposure.

Criteria

Inclusion Criteria:

  • Included in Maine EMS database
  • House Fire Victim
  • Poisoning

Exclusion Criteria:

  • No potential cyanide exposure
  • Incomplete data available
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01656616

Contacts
Contact: Tania D Strout, PhD, RN, MS 207-662-7049 strout@mmc.org

Locations
United States, Maine
Maine Medical Center Department of Emergency Medicine Not yet recruiting
Portland, Maine, United States, 04102
Principal Investigator: Tamas Peredy, MD            
Sub-Investigator: Tania D Strout, PhD, RN, MS            
Sponsors and Collaborators
Maine Medical Center
Investigators
Study Director: Tania D Strout, PhD, RN, MS Maine Medical Center
  More Information

No publications provided

Responsible Party: Tania D. Strout, Director of Research, Department of Emergency Medicine, Maine Medical Center
ClinicalTrials.gov Identifier: NCT01656616     History of Changes
Other Study ID Numbers: IRB 4053X
Study First Received: August 1, 2012
Last Updated: August 2, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Maine Medical Center:
Pharmacoeconomics
Cost effectiveness
Cyanide
 Fire
Emergency Medical Services
Smoke Inhalation

Additional relevant MeSH terms:
Emergencies
Poisoning
Disease Attributes
Pathologic Processes
Substance-Related Disorders
Antidotes
Hydroxocobalamin
Vitamin B 12
Protective Agents
 Physiological Effects of Drugs
Pharmacologic Actions
Vitamin B Complex
Vitamins
Micronutrients
Growth Substances
Hematinics
Hematologic Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 22, 2013